Sustained Release (like May & Baker’s UK – ORUVAIL capsules)
Posology
Once daily
Raw Material
DMF available
Chemical Pharmaceutical Dossier
Available
Parmacokinetics
Multiple dose (steady state) two-way crossover bioequivalence study vs. May & Baker’s (UK) ORUVAIL, ketoprofen sustained release 200 mg capsules. New bioequivalence studies are under-way.
Registration underway
Marketing
Bangladesh, Egypt, Finland, Greece, New Zealand, Poland, Republic of South Africa, Romania, United King-dom, Tunisia.
